Tobradex contains an antibiotic and a steroid, so it is not the first-line choice for pure allergic conjunctivitis, which is typically managed with antihistamine or mast-cell stabiliser drops. If a bacterial component is suspected, a clinician may consider it, but the steroid component warrants careful monitoring.
The standard UK packaging shows a white bottle with a blue cap, embossed with the brand name “Tobradex” and the concentration “0.1 %/0.3 %”. The batch number and expiry date are printed on the label, not on the bottle itself.
Contact lenses should be removed before instilling Tobradex and re-inserted only after the drops have been absorbed (generally after 15 minutes). The preservative in the formulation may adhere to the lens surface and cause irritation.
Combining the two agents in a single bottle ensures simultaneous delivery and reduces the number of instillations. Pharmacologically the effect is equivalent to using each component separately, provided the same concentrations are used.
Topical ophthalmic use of Tobradex is unlikely to produce systemic levels that trigger standard doping tests. However, athletes subject to strict anti-doping regulations should disclose any medication to their medical team.
Post-keratoplasty regimens often include a corticosteroid and an antibiotic, but the specific agents and concentrations differ. Tobradex may be used only if the transplant surgeon explicitly prescribes it, taking into account the risk of graft rejection and infection.
If the tip contacts the ocular surface, wipe it with a clean tissue and replace the cap. Avoid using a contaminated bottle, as this can introduce pathogens to the eye.
Tobradex contains benzalkonium chloride (BAK) as a preservative. BAK can cause mild irritation in some individuals, especially with prolonged use. Patients experiencing persistent discomfort should discuss preservative-free alternatives with their ophthalmologist.
Patients often notice a reduction in redness and swelling within 24-48 hours, though the full anti-inflammatory effect may require several days of consistent dosing.
No direct food interactions are documented for topical Tobradex. However, maintaining a balanced diet supports overall ocular health and may aid recovery.
Tobradex is an ophthalmic suspension formulated as a sterile eye-drop bottle. It contains two active ingredients: tobramycin (an aminoglycoside antibiotic) and dexamethasone (a potent corticosteroid). The product is supplied in a 0.1 %/0.3 % concentration, meaning each millilitre provides 0.1 % dexamethasone and 0.3 % tobramycin. In the United Kingdom, Tobradex is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). It is commonly used by eye-care professionals to manage bacterial eye infections and associated inflammation.
Tobramycin binds to the bacterial 30 S ribosomal subunit, interfering with protein synthesis and leading to bacterial cell death. Its activity is strongest against Gram-negative organisms such as Pseudomonas aeruginosa and also covers many Gram-positive strains.
Dexamethasone is a synthetic glucocorticoid that penetrates ocular tissues and suppresses the inflammatory cascade. It reduces the release of prostaglandins, leukotrienes, and cytokines, thereby diminishing redness, swelling, and pain.
The combination allows simultaneous eradication of pathogenic bacteria and control of the inflammatory response that often accompanies ocular infection or postoperative irritation.
After instillation, the suspension distributes over the ocular surface. Peak antimicrobial activity is reached within minutes, while the anti-inflammatory effect persists for several hours due to the relatively long ocular half-life of dexamethasone.
Tobradex is approved in the UK for the following indications:
These indications reflect the dual need to control infection and mitigate inflammation in the eye.
Who may benefit
Absolute contraindications
Relative contraindications
Special populations
These effects are usually transient and resolve without intervention.
If any of the following occur, seek urgent ophthalmic care: severe pain, sudden loss of vision, marked swelling, or signs of a new infection.
Patients should inform their ophthalmologist of all eye medications, including over-the-counter lubricants and herbal preparations.
Standard dosing: For most infections, the usual regimen is one to two drops in the affected eye(s) every 4 hours (6-8 times daily) during the first 48 hours, then taper to four times daily until the infection resolves, typically 5-7 days.
Post-operative protocol: Surgeons may prescribe a more intensive schedule (e.g., every 2 hours for the first 24 hours) followed by the standard regimen.
Administration tips:
Wash hands thoroughly before handling the bottle.
Shake the bottle gently to ensure an even suspension.
Pull the lower eyelid down, place one drop into the conjunctival sac, and close the eye gently for 1-2 minutes.
Avoid touching the tip of the bottle to the eye or any surface to prevent contamination.
Missed dose: Instill a drop as soon as it is remembered unless the next scheduled dose is less than an hour away; do not double the dose.
Overdose: Excessive use may increase the risk of ocular hypertension and systemic absorption of tobramycin. Symptoms can include persistent burning, blurred vision, and, rarely, signs of aminoglycoside toxicity (tinnitus, dizziness). Seek medical attention promptly.
Discontinuation: If therapy is stopped abruptly after prolonged use (>2 weeks), a tapering schedule (gradual reduction of frequency) may be recommended to avoid rebound inflammation.
Regular follow-up appointments with an ophthalmologist are essential, especially when treating corneal ulcers or postoperative inflammation.
If the suspension appears discolored, contains particles, or has an unusual odor, discard it and obtain a new prescription.
This article provides educational information about Tobradex and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
